Management of spinal deformities and tibial pseudarthrosis in children with neurofibromatosis type 1 (NF-1)

被引:17
|
作者
Mladenov, Kiril V. [1 ]
Spiro, Alexander Simon [1 ]
Krajewski, Kara Leigh [1 ]
Stuecker, Ralf [1 ]
Kunkel, Philip [1 ]
机构
[1] Altona Childrens Hosp AKK UKE, Bleickenallee 38, D-22763 Hamburg, Germany
关键词
Neurofibromatosis type 1; Dystrophic scoliosis; Congenital pseudarthrosis of the tibia; CONGENITAL PSEUDOARTHROSIS; SCOLIOSIS; NF1; PREVALENCE; HAMARTOMA; FUSION;
D O I
10.1007/s00381-020-04775-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A Summary of background data The skeletal system is affected in up to 60% of patients with neurofibromatosis type 1. The most commonly observed entities are spinal deformities and tibial dysplasia. Early recognition of radiologic osseous dystrophy signs is of utmost importance because worsening of the deformities without treatment is commonly observed and surgical intervention is often necessary. Due to the relative rarity and the heterogenic presentation of the disease, evidence regarding the best surgical strategy is still lacking. Purpose To report our experience with the treatment of skeletal manifestations in pediatric patients with (neurofibromatosis type 1) NF-1 and to present the results with our treatment protocols. Materials and methods This is a retrospective, single expert center study on children with spinal deformities and tibial dysplasia associated with NF-1 treated between 2006 and 2020 in a tertiary referral institution. Results Spinal deformity:Thirty-three patients (n = 33) were included. Mean age at index surgery was 9.8 years. In 30 patients (91%), the deformity was localized in the thoracic and/or lumbar spine, and in 3 patients (9%), there was isolated involvement of the cervical spine. Eleven patients (33%) received definitive spinal fusion as an index procedure and 22 (67%) were treated by means of "growth-preserving" spinal surgery. Halo-gravity traction before index surgery was applied in 11 patients (33%). Progression of deformity was stopped in all patients and a mean curve correction of 60% (range 23-98%) was achieved. Mechanical problems with instrumentation requiring revision surgery were observed in 55% of the patients treated by growth-preserving techniques and in none of the patients treated by definitive fusion. One patient (3%) developed a late incomplete paraplegia due to a progressive kyphotic deformity. Tibial dysplasia:The study group comprised of 14 patients. In 5 of them (36%) pathological fractures were present on initial presentation. In the remaining 9 patients (64%), anterior tibial bowing without fracture was observed initially. Four of them (n = 4, 28%) subsequently developed a pathologic fracture despite brace treatment. Surgical treatment was indicated in 89% of the children with pathological fractures. This involved resection of the pseudarthrosis, autologous bone grafting, and intramedullary nailing combined with external fixation in some of the cases. In 50% of the patients, bone morphogenic protein was used "off-label" in order to promote union. Healing of the pseudarthrosis was achieved in all of the cases and occurred between 5 to 13 months after the index surgical intervention. Four of the patients treated surgically needed more than one surgical intervention in order to achieve union; one patient had a re-fracture. All patients had a good functional result at last follow-up. Conclusion Early surgical intervention is recommended for the treatment dystrophic spinal deformity in children with NF-1. Good and sustainable curve correction without relevant thoracic growth inhibition can be achieved with growth-preserving techniques alone or in combination with short spinal fusion at the apex of the curve. Preoperative halo-gravity traction is a safe and very effective tool for the correction of severe and rigid deformity in order to avoid neurologic injury. Fracture union in tibial dysplasia with satisfactory functional results can be obtained in over 80% of the children by means of surgical resection of the pseudarthrosis, intramedullary nailing, and bone grafting. Wearing a brace until skeletal maturity is achieved is mandatory in order to minimize the risk of re-fracture.
引用
收藏
页码:2409 / 2425
页数:17
相关论文
共 50 条
  • [21] Spinal deformities in neurofibromatosis 1
    Lechevallier, J.
    Foulongne, E.
    Goldenberg, A.
    Abuamara, S.
    Sucato, D.
    ARCHIVES DE PEDIATRIE, 2008, 15 (05): : 731 - 733
  • [22] Epidemiology and Outcomes of Neurofibromatosis Type 1 (NF-1): Multicenter Tertiary Experience
    Almuqbil, Mohammed
    Alshaikh, Fatimah Yaseen
    Altwaijri, Waleed
    Baarmah, Duaa
    Hommady, Raid Harb
    Alshaikh, Maryam Yaseen
    Alammari, Fares
    Alhussain, Meshal
    Almotawa, Reem
    Alqarni, Faris
    Kashgari, Amna
    Alkhodair, Rayan
    Alkhater, Jumanah N.
    Alkhater, Lujeen Nasser
    Alharthi, Sawsan A.
    Alsadi, Mada Abdulkarim
    AlRumayyan, Ahmed
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2024, 17 : 1303 - 1314
  • [23] Pseudarthrosis in neurofibromatosis type 1
    Ramelli, GP
    Slongo, T
    Weis, J
    Tschäppler, H
    Vassella, F
    KLINISCHE PADIATRIE, 2000, 212 (01): : 26 - 30
  • [24] Brainstem Gliomas (BSGs) in Neurofibromatosis Type 1 (NF-1): The Children's National Health System Experience
    Sato, A.
    Vezina, G.
    Packer, R.
    ANNALS OF NEUROLOGY, 2016, 80 : S379 - S379
  • [25] Growth hormone deficiency in children with neurofibromatosis type 1 (NF-1) who have no suprasellar lesions.
    Vassilopoulou-Sellin, R
    Klein, MJ
    Slopis, JK
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (07) : 221A - 221A
  • [26] Homocystinuria (HC) and Neurofibromatosis Type-1 (NF-1): An Unusual Presentation in a Child
    Yaqub, Muhammad Amer
    Khan, Muhammad Saim
    Habib, Asad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (11): : S140 - S141
  • [27] Feasibility of Gene Replacement Therapy in Neurofibromatosis Type 1 (NF-1)-Related Tumors
    Bai, Renyuan
    Staedtke, Verena
    MOLECULAR THERAPY, 2019, 27 (04) : 167 - 168
  • [28] Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1
    Stevenson, DA
    Birch, PH
    Friedman, JM
    Viskochil, DH
    Balestrazzi, P
    Boni, S
    Buske, A
    Korf, BR
    Niimura, M
    Pivnick, EK
    Schorry, EK
    Short, MP
    Tenconi, R
    Tonsgard, JH
    Carey, JC
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 84 (05): : 413 - 419
  • [29] Dystrophic Spinal Deformities in a Neurofibromatosis Type 1 Murine Model
    Rhodes, Steven D.
    Zhang, Wei
    Yang, Dalong
    Yang, Hao
    Chen, Shi
    Wu, Xiaohua
    Li, Xiaohong
    Yang, Xianlin
    Mohammad, Khalid S.
    Guise, Theresa A.
    Bergner, Amanda L.
    Stevenson, David A.
    Yang, Feng-Chun
    PLOS ONE, 2015, 10 (03):
  • [30] Neurobehavioral children with NF-1
    Boulanger, JM
    Larbrisseau, A
    Lebel, M
    Huete, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 60 - 60